Table 2 Baseline characteristics in patients with or without cardiovascular events
Variables | Total | MACE | Non-MACE | P value |
|---|---|---|---|---|
Baseline characteristics | ||||
 Patients (n, %) | 9091 | 1017 (11.1%) | 8074 (88.9%) |  |
 Age (years) | 57.22 ± 10.37 | 59.81 ± 9.98 | 56.89 ± 10.38 |  < 0.001 |
 Male (n, %) | 6431 (70.7%) | 687 (67.6%) | 5744 (71.1%) | 0.018 |
 Hypertension (n, %) | 5591 (61.5%) | 677 (66.6%) | 4914 (60.9%) |  < 0.001 |
 Dyslipidemia (n, %) | 6759 (74.3%) | 751 (73.8%) | 6008 (74.4%) | 0.696 |
 Diabetes mellitus (n, %) | 3173 (34.9%) | 425 (41.8%) | 2748 (34.0%) |  < 0.001 |
 BMI (kg/m2) | 25.89 ± 3.23 | 25.74 ± 3.23 | 25.90 ± 3.23 | 0.121 |
 Current smoking (n, %) | 2880 (31.7%) | 280 (27.5%) | 2600 (32.2%) | 0.003 |
 Family history of CAD (n, %) | 1207 (13.3%) | 130 (12.8%) | 1077 (13.3%) | 0.622 |
Laboratory data | ||||
 TC (mmol/L) | 4.14 ± 1.12 | 4.15 ± 1.12 | 4.14 ± 1.12 | 0.805 |
 TG (mmol/L) | 1.79 ± 1.23 | 1.81 ± 1.47 | 1.79 ± 1.20 | 0.580 |
 LDL-C (mmol/L) | 2.51 ± 0.99 | 2.49 ± 0.92 | 2.51 ± 1.00 | 0.532 |
 HDL-C (mmol/L) | 1.07 ± 0.29 | 1.07 ± 0.29 | 1.07 ± 0.29 | 0.569 |
 Apo A1 (g/L) | 1.34 ± 0.30 | 1.36 ± 0.30 | 1.34 ± 0.30 | 0.086 |
 Apo B (g/L) | 0.91 ± 0.28 | 0.93 ± 0.30 | 0.91 ± 0.29 | 0.211 |
 Glucose (mmol/L) | 5.85 ± 2.56 | 5.87 ± 1.80 | 5.83 ± 1.75 | 0.551 |
 HbA1c (%) | 6.29 ± 1.09 | 6.47 ± 1.20 | 6.27 ± 1.09 |  < 0.001 |
 Creatinine (mmol/L) | 77.33 ± 17.46 | 77.93 ± 17.29 | 77.25 ± 17.48 | 0.246 |
Treatment in hospital | ||||
 Aspirin (n, %) | 8595 (94.5%) | 984 (96.8%) | 7611 (94.3%) | 0.001 |
 β-Blockers (n, %) | 6846 (75.3%) | 802 (78.9%) | 6044 (74.9%) | 0.005 |
 CCBs (n, %) | 3356 (36.9%) | 403 (39.6%) | 2953 (36.6%) | 0.057 |
 ACE inhibitors (n, %) | 2045 (22.5%) | 273 (26.8%) | 1772 (21.9%) |  < 0.001 |
 ARB (n, %) | 2150 (23.6%) | 291 (28.6%) | 1859 (23.0%) |  < 0.001 |
 Lipid-lowering medication (n, %) | 8159 (89.7%) | 958 (94.2%) | 7201 (89.2%) |  < 0.001 |
 Anti-diabetes drugs (n, %) | 3173 (34.9%) | 425 (41.8%) | 2748 (34.0%) |  < 0.001 |
 Coronary revascularization (n, %) | 4493 (49.4%) | 500 (49.2%) | 3993 (49.6%) | 0.861 |
Severity of coronary disease | ||||
 NOCAS (n, %) | 1290 (14.2%) | 90 (8.8%) | 1200 (14.9%) |  < 0.001 |
 ICAS (n, %) | 1003 (11.0%) | 94 (9.2%) | 909 (11.3%) | 0.056 |
 SCAS (n, %) | 6798 (74.8%) | 833 (81.9%) | 5965 (73.9%) |  < 0.001 |